尿石症的医学评估和管理。
Medical evaluation and management of urolithiasis.
机构信息
The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
出版信息
Ther Adv Urol. 2010 Feb;2(1):3-9. doi: 10.1177/1756287210369121.
Abstract
Nephrolithiasis is a highly prevalent condition with a high recurrence rate that has a large impact on the quality of life of those affected. It also poses a great financial burden on society. There have been great advancements in the surgical treatment of stone disease over the past several decades. The evolution of surgical technique appears to have overshadowed the importance of prevention of stone disease despite evidence showing medical therapies significantly decreasing stone recurrence rates. Herein we review the metabolic evaluation of stone formers with the use of specific blood and urine tests. We complete our discussion with a review of the medical management of stone formers providing both general recommendations as well as reviewing focused therapies for specific metabolic abnormalities and medical conditions.
摘要
肾结石是一种高发疾病，复发率高，对患者的生活质量有很大影响，同时也给社会带来了巨大的经济负担。在过去的几十年中，结石病的外科治疗取得了很大的进展。尽管有证据表明药物治疗可以显著降低结石复发率，但手术技术的发展似乎掩盖了结石病预防的重要性。本文回顾了结石患者的代谢评估，包括使用特定的血液和尿液检查。我们还讨论了结石患者的药物治疗，提供了一般建议，并回顾了针对特定代谢异常和医疗状况的针对性治疗。
相似文献
1
Medical evaluation and management of urolithiasis.尿石症的医学评估和管理。
Ther Adv Urol. 2010 Feb;2(1):3-9. doi: 10.1177/1756287210369121.
2
Urolithiasis: Update on Metabolic Evaluation of Stone Formers.尿石症：结石形成者代谢评估的最新进展。
ScientificWorldJournal. 2005 Nov 11;5:902-914. doi: 10.1100/tsw.2005.118. eCollection 2005.
3
Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers.确定肾结石的代谢活性 - 结石形成者的适当评估与随访
Asian J Urol. 2018 Oct;5(4):235-242. doi: 10.1016/j.ajur.2018.06.007. Epub 2018 Jun 26.
4
Update on nephrolithiasis management.肾结石治疗的最新进展。
Minerva Urol Nefrol. 2007 Sep;59(3):317-25.
5
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.代谢评估和预防尿路结石患者复发：EAU 指南。
Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
6
No stone unturned: The epidemiology and outcomes of paediatric urolithiasis in Manchester, United Kingdom.不遗余力：英国曼彻斯特小儿尿路结石病的流行病学及转归
J Pediatr Urol. 2020 Jun;16(3):372.e1-372.e7. doi: 10.1016/j.jpurol.2020.03.009. Epub 2020 Mar 19.
7
8
Urolithiasis--medical therapies.尿石症——医学疗法。
BJU Int. 2011 Nov;108 Suppl 2:9-13. doi: 10.1111/j.1464-410X.2011.10688.x.
9
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
10
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.国际尿石症联盟（IAU）尿路结石代谢评估与医学管理指南。
Urolithiasis. 2022 Dec 1;51(1):4. doi: 10.1007/s00240-022-01387-2.
引用本文的文献
1
Outcomes and Complications from a Randomized Controlled Study Comparing Conventional Stent Placement Versus No Stent Placement after Ureteroscopy for Distal Ureteric Calculus < 1 cm.一项随机对照研究的结果与并发症：比较输尿管镜检查后对直径<1 cm的输尿管下段结石进行传统支架置入与不置入支架的情况
J Clin Med. 2022 Nov 28;11(23):7023. doi: 10.3390/jcm11237023.
2
Antioxidant and Polyphenol-Rich Ethanolic Extract of L. Prevents Urolithiasis in an Ethylene Glycol Experimental Model in Rats.L 的抗氧化剂和多酚丰富的乙醇提取物可预防大鼠乙二醇实验性结石模型中的尿石症。
Molecules. 2021 Feb 14;26(4):1005. doi: 10.3390/molecules26041005.
3
Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial.单纯输尿管镜碎石术后输尿管支架置入与不置入的比较：一项前瞻性随机试验。
Arab J Urol. 2020 May 19;18(3):169-175. doi: 10.1080/2090598X.2020.1762280.
4
Predictive Factors for Achieving the Recommended AUA Daily Urine Production in Patients With Nephrolithiasis.肾结石患者达到美国泌尿外科学会推荐的每日尿量的预测因素
Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):141-148. doi: 10.1016/j.mayocpiqo.2019.02.006. eCollection 2019 Jun.
5
Protective effect of ethyl acetate fraction of extract against sodium oxalate-induced urolithiasis in rats.提取物乙酸乙酯部位对草酸钠诱导的大鼠尿路结石的保护作用。
J Tradit Complement Med. 2017 Jan 17;7(4):476-486. doi: 10.1016/j.jtcme.2016.12.012. eCollection 2017 Oct.
6
Detector-based spectral CT with a novel dual-layer technology: principles and applications.基于探测器的新型双层技术光谱CT：原理与应用
Insights Imaging. 2017 Dec;8(6):589-598. doi: 10.1007/s13244-017-0571-4. Epub 2017 Oct 6.
7
Effects of commercial citrate-containing juices on urolithiasis in a Drosophila model.商业含枸橼酸盐果汁对果蝇模型尿石症的影响。
Kaohsiung J Med Sci. 2013 Sep;29(9):488-93. doi: 10.1016/j.kjms.2013.01.003. Epub 2013 Apr 20.
8
Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.氢氯噻嗪与氯噻酮降低肾结石患者尿钙比较。
Urolithiasis. 2013 Aug;41(4):315-22. doi: 10.1007/s00240-013-0568-5. Epub 2013 May 10.
本文引用的文献
1
Hypocitraturia: pathophysiology and medical management.低枸橼酸尿症：病理生理学与药物治疗
Rev Urol. 2009 Summer;11(3):134-44.
2
Effect of potassium depletion on urinary stone risk factors in Wistar rats.钾缺乏对Wistar大鼠尿路结石危险因素的影响。
Urol Res. 2009 Dec;37(6):311-6. doi: 10.1007/s00240-009-0220-6. Epub 2009 Oct 16.
3
Differentiating primary from secondary hyperparathyroidism in stone patients: the "thiazide challenge".区分结石患者的原发性甲状旁腺功能亢进与继发性甲状旁腺功能亢进：“噻嗪类药物激发试验”
J Endourol. 2009 Feb;23(2):191-2. doi: 10.1089/end.2008.0567.
4
Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.饮食变化对高草酸尿性结石形成患者尿草酸排泄及草酸钙过饱和度的影响。
Urology. 2009 Mar;73(3):484-9. doi: 10.1016/j.urology.2008.10.035. Epub 2009 Jan 1.
5
Medical therapy of stone disease: from prevention to promotion of passage options.结石病的医学治疗：从预防到促进排石选择
Curr Urol Rep. 2009 Jan;10(1):29-34. doi: 10.1007/s11934-009-0007-x.
6
Urinary metabolic evaluations in solitary and recurrent stone forming children.孤立性和复发性结石形成儿童的尿液代谢评估
J Urol. 2008 Jun;179(6):2369-72. doi: 10.1016/j.juro.2008.01.151. Epub 2008 Apr 23.
7
Prevention of stone disease.结石病的预防。
Urol Int. 2007;79 Suppl 1:37-46. doi: 10.1159/000104440.
8
Laboratory assessment.实验室评估。
Urol Int. 2007;79 Suppl 1:20-5. doi: 10.1159/000104437.
9
Renal histopathology of stone-forming patients with distal renal tubular acidosis.远端肾小管酸中毒结石形成患者的肾脏组织病理学
Kidney Int. 2007 Apr;71(8):795-801. doi: 10.1038/sj.ki.5002113. Epub 2007 Jan 31.
10
Renal stone disease: Causes, evaluation and medical treatment.肾结石病：病因、评估与药物治疗
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):823-31. doi: 10.1590/s0004-27302006000400027.
Zotero 插件